Document is current
Any future updates will be listed below
-
Authors
Wu, Jinsong
Wu, Shuai
Cao, Dandan
Xiong, Zhang
Zhang, Jianhua
Zou, Yourui
Wu, Zanyi
Nie, Yanli
Luo, Chen
Yao, Ye
Song, Yanyan
Jiao, Yuchen
Chen, Hong
Ma, Hui
Kang, Dezhi
Mao, Ying
Yan, Hai
-
Funding
Funding for this research was provided by:
Shanghai Hospital Development Center (SHDC2022CRD023, SHDC2024CRI089, SHDC2020CR5004)
Department of Science and Technology of Ningxia Hui Autonomous Region (2024FRD05099, 2024FRD05099, 2024FRD05099, 2024FRD05099)
Science and Technology Commission of Shanghai Municipality (23Y11900700)
Shanghai Municipal Health Commission (2024ZZ2026, 2022ZZ01006)
- License Information
-
More Information
Article History
Received: 4 June 2024
Accepted: 13 May 2025
First Online: 2 June 2025
Declarations
:
: This study was registered in the ClinicalTrials.gov (NCT04924127, NCT04904419). All patients and samples used in this study were approved by the institutional review boards of Huashan Hospital of Fudan University (2019–539, 2020–1298), General Hospital of Ningxia Medical University (KYLL-2021–242), and the First Affiliated Hospital of Fujian Medical University (MRCTA, ECFAH of FMU [2021]120).
: Not applicable.
: Hai Yan is the Co-founder of Genetron Health, and receives royalties from Agios, Genetron Health and Personal Genome Diagnostics (PGDX). Other authors declare no conflict of interest.
